Literature DB >> 8899717

Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon.

C Coynault1, V Robbe-Saule, F Norel.   

Abstract

The alternative sigma factor RpoS (sigma S) is required for Salmonella virulence in mice. We report the immunizing capacity of Salmonella typhimurium rpoS and rpoS aroA mutants to protect susceptible BALB/c mice against subsequent oral challenge with virulent S. typhimurium. When administered orally or intraperitoneally, rpoS derivatives of the mouse-virulent S. typhimurium strains, C52 and SL1344, were highly attenuated and were efficient single-dose live vaccines. rpoS aroA mutants were more attenuated than corresponding single aroA or rpoS mutants, as assessed after oral or intraperitoneal administration, but retained significant ability to protect mice against salmonellosis. Salmonella rpoS and rpoS aroA mutants therefore deserve serious consideration for rational vaccine design. Consistent with this, Salmonella typhi Ty2, a 'wild-type' strain used widely for the development of human live-vaccine candidates against typhoid fever, was shown to be defective for rpoS. In addition, our results demonstrate that rpoS not only controls the growth and persistence of S. typhimurium in deep lymphoid organs, but also plays a role during the initial stages of oral infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899717     DOI: 10.1111/j.1365-2958.1996.tb02664.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  55 in total

1.  OmpR regulates the two-component system SsrA-ssrB in Salmonella pathogenicity island 2.

Authors:  A K Lee; C S Detweiler; S Falkow
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

Review 2.  Microbial responses to microgravity and other low-shear environments.

Authors:  Cheryl A Nickerson; C Mark Ott; James W Wilson; Rajee Ramamurthy; Duane L Pierson
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 3.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 4.  Alternative sigma factors and their roles in bacterial virulence.

Authors:  Mark J Kazmierczak; Martin Wiedmann; Kathryn J Boor
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

5.  The Rcs phosphorelay system is specific to enteric pathogens/commensals and activates ydeI, a gene important for persistent Salmonella infection of mice.

Authors:  Kimberly D Erickson; Corrella S Detweiler
Journal:  Mol Microbiol       Date:  2006-09-29       Impact factor: 3.501

Review 6.  Live attenuated vaccines for invasive Salmonella infections.

Authors:  Sharon M Tennant; Myron M Levine
Journal:  Vaccine       Date:  2015-04-19       Impact factor: 3.641

7.  Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Soo-Young Wanda; Cheryl A Nickerson; Roy Curtiss
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

8.  Identification of conserved amino acid residues of the Salmonella sigmaS chaperone Crl involved in Crl-sigmaS interactions.

Authors:  Véronique Monteil; Annie Kolb; Jacques D'Alayer; Pierre Beguin; Françoise Norel
Journal:  J Bacteriol       Date:  2009-12-11       Impact factor: 3.490

9.  Effect of growth temperature on Crl-dependent regulation of sigmaS activity in Salmonella enterica serovar Typhimurium.

Authors:  Véronique Robbe-Saule; Ingrid Carreira; Annie Kolb; Françoise Norel
Journal:  J Bacteriol       Date:  2008-05-02       Impact factor: 3.490

10.  Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection.

Authors:  K Kaniga; M S Compton; R Curtiss; P Sundaram
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.